describ
new
method
affin
purif
recombin
protein
use
dual
proteas
protocol
escherichia
coli
maltos
bind
protein
mbp
employ
ntermin
tag
increas
yield
solubl
fusion
partner
mbp
moieti
remov
rhinoviru
proteas
prior
purif
yield
ntermin
tag
protein
protein
temporarili
render
solubl
fuse
mbp
readili
identifi
stage
precipit
mbp
tag
remov
proteas
remain
solubl
tag
protein
subsequ
purifi
immobil
metal
affin
chromatographi
imac
final
ntermin
tag
remov
tag
tobacco
etch
viru
tev
proteas
yield
nativ
recombin
protein
tag
contamin
remov
adsorpt
second
round
imac
leav
untag
recombin
protein
column
effluent
gener
strategi
describ
save
time
effort
remov
insolubl
aggreg
earli
stage
process
also
reduc
tendenc
mbp
stick
fusion
partner
affin
purif
publish
elsevi
inc
abbrevi
use
mbp
maltosebind
protein
imac
immobil
metal
ion
affin
chromatographi
tev
tobacco
etch
viru
pcr
polymeras
chain
reaction
orf
open
read
frame
chikv
chikungunya
viru
dhfr
dihydrofol
reductas
dualspecif
phosphatas
merscov
pro
middl
east
respiratori
syndrom
coronaviru
proteas
gfp
green
fluoresc
protein
rb
ribosomebind
site
iptg
isopropyl
sdsepag
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
tvmv
tobacco
vein
mottl
viru
rapid
advanc
genom
proteom
past
three
decad
revolution
field
biotechnolog
human
medicin
particularli
recombin
dna
technolog
join
hand
structur
biolog
current
sampl
protein
structur
function
studi
routin
obtain
bioengin
even
protein
purif
remain
princip
bottleneck
convent
method
protein
purif
almost
complet
supplant
affinitybas
method
employ
protein
peptid
affin
tag
popular
affinitybas
method
attribut
gener
natur
comparison
tradit
approach
rather
protein
specif
purif
platform
ion
exchang
hydrophob
interact
size
exclus
chromatographi
use
auxiliari
step
enhanc
puriti
sampl
necessari
laboratori
mani
other
dual
embp
maltosebind
protein
tag
use
initi
immobil
metal
ion
affin
chromatographi
imac
step
reason
employ
dual
tag
discuss
detail
elsewher
briefli
mbp
enhanc
solubl
improv
yield
fusion
partner
overproduct
particularli
effect
affin
tag
protein
purif
henc
tag
includ
allow
affin
chromatographi
imac
ntermin
embp
tag
subsequ
remov
tobacco
etch
viru
tev
proteas
gener
tagfre
protein
although
gener
approach
success
without
problem
instanc
signific
fraction
aggregationpron
protein
render
solubl
fuse
mbp
subsequ
precipit
fusion
protein
cleav
tev
proteas
protein
presum
either
properli
fold
exist
solubl
aggreg
partial
fold
form
usual
ascertain
whether
problem
affin
purif
second
potenti
pitfal
tendenc
protein
stick
mbp
tev
digest
make
difficult
separ
interact
mbp
fusion
partner
may
relat
mechan
solubl
enhanc
situat
usual
necessari
employ
mbptrap
amylos
column
anoth
imac
step
remov
mbp
therebi
make
purif
process
labor
intens
current
studi
attempt
circumv
problem
use
dual
proteas
approach
achiev
sequenti
remov
mbp
tag
materi
gift
sankar
adhya
francisco
malagon
addgen
plasmid
proteas
express
vector
gift
ari
geerlof
embl
heidelberg
germani
plasmid
gift
baneyx
chemic
highest
avail
puriti
purchas
sigmaealdrich
st
loui
mo
usa
american
bioanalyt
natick
usa
thermo
fisher
scientif
rockford
il
usa
roch
diagnost
indianapoli
usa
emd
millipor
billerica
usa
unless
otherwis
state
restrict
endonucleas
obtain
new
england
biolab
ipswich
usa
fastlink
dna
ligas
purchas
epicentr
madison
wi
usa
polymeras
chain
reaction
pcr
carri
use
either
pfuultra
ii
fusion
hs
dna
polymeras
agil
technolog
santa
clara
ca
usa
phusion
flash
highfidel
pcr
master
mix
thermo
fisher
scientif
gateway
destin
vector
see
fig
onlin
supplementari
materi
construct
follow
first
snabi
restrict
site
insert
end
open
read
frame
orf
encod
mbp
use
quikchang
lightn
sitedirect
mutagenesi
kit
agil
technolog
primer
tabl
gener
plasmid
next
step
c
terminu
mbp
extend
includ
infram
proteas
recognit
site
follow
tag
pcr
restrict
clone
use
primer
tabl
primer
design
anneal
proxim
bglii
site
male
gene
wherea
partial
overlap
revers
primer
employ
engin
desir
insert
site
tag
follow
snabi
restrict
site
pcr
amplicon
consist
ctermin
portion
mbp
orf
join
infram
sequenc
encod
ggglevlfq
gphhhhhhyv
digest
bglii
snabi
clone
site
yield
destin
vector
tabl
yv
residu
shown
clone
artifact
deriv
snabi
site
rhinoviru
proteas
recognit
site
underlin
cleavag
site
mark
forward
slash
see
sfgfp
orf
amplifi
singl
pcr
use
primer
revers
tabl
pcr
product
contain
nand
ctermin
attb
recombin
site
tev
proteas
recognit
site
append
n
terminu
sfgfp
orf
pcr
amplicon
use
gateway
bp
reaction
thermo
fisher
scientif
gener
entri
clone
tabl
similarli
chikungunya
viru
chikv
proteas
orf
amplifi
chikv
cdna
clone
use
primer
revers
tabl
pcr
amplicon
use
gateway
bp
reaction
gener
entri
clone
tabl
addit
entri
clone
encod
francisella
tularensi
iglc
human
dihydrofol
reductas
dhfr
human
dual
specif
phosphatas
human
sumoconjug
enzym
catalyt
inact
middl
east
respiratori
syndrom
coronaviru
proteas
merscov
pro
wildtyp
green
fluoresc
protein
gfp
construct
describ
previous
destin
vector
recombin
gateway
lr
reaction
thermo
fisher
scientif
variou
entri
clone
gener
dual
proteas
express
vector
studi
express
vector
list
tabl
schemat
represent
mbp
fusion
protein
produc
shown
fig
second
proteas
recognit
site
correspond
tev
proteas
incorpor
entri
clone
gateway
recombin
clone
thermo
fisher
scientif
use
make
untag
rhinoviru
proteas
express
vector
colysi
experi
proteas
orf
amplifi
pcr
use
primer
tabl
primer
incorpor
attb
recombin
site
along
appropri
posit
ribosomebind
site
rb
pcr
product
subsequ
pcr
product
use
bp
reaction
thermo
fisher
scientif
gener
entri
clone
entri
clone
recombin
lr
reaction
thermo
fisher
scientif
gener
tabl
primer
sequenc
sequenc
tabl
kanamycinresist
plasmid
origin
replic
larabinoseinduc
promot
creat
describ
previous
slight
variat
initi
step
desir
insert
sequenc
ori
pcramplifi
use
highfidel
dna
polymeras
forward
revers
primer
creat
mega
primer
psamrffwd
psamrfrev
respect
tabl
reaction
setup
cycl
method
templat
dna
describ
previous
mega
primer
amplicon
use
complementari
primer
subsequ
quikchang
lightn
reaction
agil
technolog
bring
desir
chang
target
plasmid
quikchang
lightn
reaction
mix
consist
target
dna
templat
ng
mega
primer
amplicon
ng
along
pcr
compon
cycl
method
follow
c
segment
c
c
min
c
min
segment
cycl
c
c
min
c
min
segment
cycl
target
plasmid
quikchang
reaction
reaction
mix
instead
earlier
method
deriv
carri
arabinoseinduc
p
bad
promot
arac
gene
instead
promot
thu
effect
replicon
replac
replicon
modifi
vector
tabl
confirm
pcr
dna
sequenc
induct
vector
larabinos
confirm
monitor
fluoresc
protein
e
coli
cell
agil
technolog
next
proteas
orf
bracket
ndei
xhoi
site
amplifi
pcr
cleav
restrict
enzym
insert
site
gener
larabinoseinduc
untag
proteas
express
vector
tabl
protein
express
purif
e
coli
eril
cell
agil
technolog
use
protein
express
experi
except
coexpress
experi
involv
two
differ
plasmid
case
cell
use
instead
protein
express
experi
cell
grown
shake
c
luria
broth
contain
appropri
antibiot
glucos
midlog
phase
point
overexpress
fusion
protein
induc
c
h
addit
mm
iptg
cell
coexpress
fusion
protein
proteas
larabinos
ad
delay
h
follow
iptg
induct
mbp
fusion
protein
c
cultur
incub
addit
h
addit
larabinos
total
induct
induc
cell
pellet
centrifug
store
c
assess
solubl
recombin
protein
e
coli
cell
overexpress
mbp
fusion
proteas
produc
cultur
separ
resuspend
approxim
cultur
volum
icecold
sonic
buffer
mm
trisehcl
ph
mm
nacl
cell
lyse
sonic
insolubl
materi
pellet
centrifug
sampl
total
solubl
fraction
subject
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdsepag
cell
normal
od
arbitrari
set
sonic
buffer
lysi
check
proteas
activ
equal
volum
solubl
extract
cell
express
mbp
fusion
protein
proteas
combin
incub
min
c
follow
incub
supernat
analyz
sdsepag
centrifug
manner
propens
passeng
protein
precipit
proteas
digest
ie
separ
mbp
could
monitor
prior
affin
chromatographi
titrat
experi
determin
optim
amount
cell
use
colysi
protocol
determin
vari
amount
solubl
extract
contain
proteas
experi
largescal
protein
purif
perform
c
combin
cell
lysi
colysi
method
protein
purif
e
coli
cell
past
mbp
fusion
protein
g
proteas
g
suspend
togeth
ml
buffer
mm
tri
ph
mm
nacl
vv
glycerol
contain
mm
imidazol
complet
edta
ethylenediaminetetraacet
acid
free
proteas
inhibitor
cocktail
tablet
roch
diagnost
mixtur
cell
suspens
lyse
homogen
invensi
apv
product
albertslund
denmark
mpa
centrifug
g
min
supernat
filter
polyethersulfon
membran
appli
onto
histrap
ff
column
ge
healthcar
life
scienc
column
wash
baselin
buffer
contain
mm
imidazol
elut
linear
gradient
imidazol
buffer
mm
column
effluent
contain
mbp
proteas
elut
fraction
contain
tag
protein
pool
concentr
use
mwco
molecular
weight
cutoff
membran
millipor
concentr
protein
dilut
buffer
reduc
imidazol
concentr
approxim
mm
digest
overnight
tag
tev
proteas
c
digest
appli
histrap
ff
column
captur
cleav
tag
tev
column
effluent
contain
pure
protein
interest
effluent
concentr
incub
overnight
mm
dithiothreitol
c
reduc
sampl
load
onto
hiprep
sephacryl
hr
column
ge
healthcar
life
scienc
equilibr
mm
tri
ph
mm
nacl
mm
tri
phosphin
tcep
vv
glycerol
fusion
protein
use
studi
follow
modular
architectur
mbp
proteas
siteehi
siteetev
proteas
siteepasseng
protein
fig
purpos
mbp
tag
enhanc
solubl
promot
proper
fold
passeng
protein
proteas
site
allow
mbp
moieti
separ
tag
passeng
protein
prior
imac
two
benefit
first
enabl
one
determin
whether
passeng
protein
precipit
releas
mbp
chromatograph
step
perform
second
help
allevi
propens
mbp
stick
copurifi
passeng
protein
probabl
interact
less
like
persist
two
fusion
partner
longer
coval
attach
one
anoth
imac
purif
tag
passeng
protein
tag
remov
tag
tev
proteas
final
step
cleav
tag
tev
proteas
adsorb
anoth
imac
step
leav
pure
untag
passeng
protein
column
effluent
remov
mbp
proteas
accomplish
either
two
way
one
approach
e
coli
cell
past
contain
overproduc
fusion
protein
mix
cell
past
contain
proteas
lyse
togeth
proteas
highli
activ
low
temperatur
rapidli
cleav
fusion
protein
process
sampl
altern
proteas
coexpress
fusion
protein
substrat
purpos
arabinoseinduc
proteas
vector
use
enabl
product
proteas
control
independ
iptginduc
fusion
protein
express
vector
abil
delay
induct
proteas
express
import
advantag
prolong
associ
mbp
passeng
protein
stimul
proper
fold
studi
shown
length
sequenc
linker
connect
mbp
passeng
protein
profound
impact
solubl
mbp
fusion
protein
henc
import
assess
solubl
mbp
fusion
protein
linker
compos
proteas
cleavag
site
follow
tag
recombin
site
artifact
gateway
clone
tev
proteas
site
respect
except
sfgfp
merscov
pro
passeng
protein
use
studi
poorli
solubl
express
unfus
form
gst
fusion
protein
e
coli
shown
fig
c
fusion
protein
modifi
linker
sequenc
express
high
level
also
highli
solubl
partial
solubl
dhfr
chikv
proteas
fusion
protein
compar
counterpart
convent
linker
untag
proteas
solubl
shown
fig
well
assess
abil
proteas
cleav
fusion
protein
substrat
crude
cell
extract
equal
volum
solubl
extract
cell
express
mbp
fusion
protein
proteas
combin
incub
min
c
result
confirm
fusion
protein
cleav
nearli
complet
short
incub
period
fig
b
prolong
incub
proteas
also
cleav
tev
recognit
site
mbp
fusion
protein
see
supplementari
materi
observ
unexpect
consid
reportedli
strict
requir
gli
pro
residu
posit
respect
proteas
recognit
site
subsequ
titrat
experi
determin
e
coli
cell
weight
ratio
fusion
protein
proteas
cell
remov
mbp
tag
effici
without
caus
nonspecif
cleavag
tev
site
fig
thu
gener
speak
l
cell
express
proteas
requir
cleav
mbp
fusion
protein
cell
obtain
l
medium
also
experi
process
mbp
fusion
protein
insid
intact
cell
coexpress
proteas
purpos
use
proteas
express
vector
induc
larabinos
independ
iptginduc
mbp
fusion
protein
express
vector
shown
fig
even
absenc
larabinos
enough
proteas
produc
cleav
major
mbpesfgfp
fusion
protein
nearli
complet
digest
obtain
presenc
arabinos
higher
concentr
larabinos
led
unintend
cleavag
tev
proteas
recognit
site
proteas
cleavag
tev
proteas
site
proteas
confirm
mass
spectrometri
see
supplementari
tabl
dual
proteas
protocol
protein
purif
consist
four
main
step
first
cell
express
proteas
combin
cell
express
appropri
design
mbp
fusion
protein
fig
lyse
togeth
cleav
mbp
tag
second
solubl
tag
passeng
protein
purifi
imac
histrap
column
third
affinitypurifi
protein
digest
tag
tev
proteas
remov
tag
translat
region
therebi
gener
nativ
protein
devoid
tag
clone
artifact
possibl
except
ntermin
glycin
residu
final
pure
protein
collect
effluent
second
histrap
column
serv
remov
tag
tev
proteas
residu
undigest
histag
passeng
protein
second
imac
step
also
aid
remov
nonspecif
protein
appear
first
imac
elut
gel
filtrat
column
recommend
final
polish
step
mean
remov
solubl
aggreg
may
present
evalu
efficaci
gener
protocol
purifi
gfp
sfgfp
iglc
chikv
proteas
merscov
pro
produc
mbp
fusion
protein
type
depict
fig
everi
step
puriti
protein
monitor
sdsepag
fig
cleavag
product
gener
proteas
tev
proteas
also
analyz
electrospray
ioniz
mass
spectroscopi
along
purif
rout
phosphatas
activ
visibl
green
fluoresc
confirm
proper
fold
purifi
gfp
respect
data
shown
follow
final
buffer
exchang
gel
filtrat
column
enhanc
homogen
purifi
protein
judg
pure
sdsepag
fig
molecular
weight
confirm
electrospray
ioniz
mass
spectroscopi
final
yield
purifi
passeng
protein
rang
mg
per
gram
wet
e
coli
cell
weight
extraordinari
abil
mbp
enhanc
yield
promot
solubl
fusion
partner
well
document
particularli
good
affin
tag
protein
purif
therefor
other
employ
gener
strategi
protein
express
purif
combin
solubilityenhanc
benefit
confer
mbp
power
advantag
immobil
metal
affin
chromatographi
use
polyhistidin
tag
tandem
configur
mbp
embp
although
frequent
success
approach
two
potenti
pitfal
first
mani
aggregationpron
protein
render
solubl
fuse
mbp
subsequ
precipit
separ
solubl
enhanc
second
mbp
tendenc
form
noncoval
complex
passeng
protein
complic
downstream
purif
first
problem
occur
passeng
protein
unabl
fold
properli
either
spontan
assist
endogen
chaperon
compet
kinet
pathway
aggreg
block
fuse
mbp
current
gener
effect
solut
problem
howev
method
report
mbp
cleav
passeng
protein
crude
cell
extract
enabl
mani
dead
end
case
spot
earli
prior
purif
fusion
protein
affin
chromatographi
still
occasion
passeng
protein
may
remain
solubl
biolog
inact
releas
mbp
possibl
fusion
mbp
enabl
certain
protein
evolv
kinet
trap
fold
intermedi
longer
suscept
aggreg
therefor
advis
employ
biolog
assay
possibl
earli
stage
confirm
passeng
protein
properli
fold
second
advantag
cleav
mbp
fusion
protein
prior
affin
purif
reduc
tendenc
mbp
stick
cleav
passeng
protein
purif
characterist
mbp
may
relat
mechan
promot
solubl
inhibit
aggreg
thought
involv
format
transient
complex
mbp
partial
fold
passeng
protein
although
amino
acid
surround
proteas
cleavag
site
fusion
protein
cleav
equal
effici
fig
b
like
explan
fusion
exist
form
solubl
aggreg
therebi
mask
cleavag
site
also
observ
case
embp
fusion
protein
bind
readili
imac
eg
ninta
resin
wherea
correspond
fusion
protein
gener
cleavag
could
due
obstruct
tag
present
n
terminu
passeng
protein
oppos
attach
n
terminu
mbp
exemplifi
see
fig
supplementari
materi
ineffici
bind
tag
passeng
imac
necessarili
indic
unfold
protein
howev
least
unbound
enzymat
activ
data
shown
donnelli
cowork
describ
similar
dual
proteas
approach
use
tobacco
vein
mottl
viru
tvmv
tev
proteas
howev
method
present
two
noteworthi
advantag
first
proteas
use
instead
tvmv
proteas
separ
mbp
histag
passeng
protein
proteas
superior
tvmv
proteas
highli
activ
low
temperatur
consequ
reaction
proce
effici
ice
moreov
donnelli
cowork
method
fusion
protein
cleav
tvmv
proteas
insid
intact
cell
yet
express
tvmv
proteas
constitut
result
rapid
cleavag
mbp
fusion
protein
follow
translat
signific
evid
suggest
longer
protein
remain
fuse
mbp
like
fold
correctli
although
delay
induct
proteas
gene
plasmid
vivo
intracellular
process
larabinos
induct
proteas
mbpesfgfp
fusion
protein
digest
vivo
coexpress
proteas
vari
degre
indic
presenc
absenc
iptg
larabinos
mark
leaki
express
proteas
caus
partial
digest
mbpesfgfp
first
lane
left
molecular
weight
marker
arabinos
intend
solv
problem
unfortun
enough
proteas
produc
absenc
induc
cleav
substanti
portion
wellexpress
mbpesfgfp
fusion
protein
vivo
fig
henc
recommend
employ
novel
colysi
method
proteas
cleavag
instead
dual
proteas
strategi
protein
express
purif
describ
simpl
univers
applic
exampl
mbp
fusion
protein
express
insect
cell
host
could
colys
e
coli
cell
contain
proteas
desir
necessari
develop
mean
coexpress
proteas
differ
host
moreov
although
attrit
rate
may
seemingli
appear
higher
associ
use
dual
embp
tag
singl
proteas
protein
purifi
use
dual
proteas
approach
like
would
also
prove
problemat
convent
approach
employ
later
stage
consider
greater
expenditur
time
effort
